PMDA — authorised 25 August 2021
- Marketing authorisation holder: MARUISHI PHARMACEUTICAL Co., Ltd
- Status: approved
🇯🇵 Sodium Nitroprusside in Japan
PMDA authorised Sodium Nitroprusside on 25 August 2021
Marketing authorisation
Sodium Nitroprusside in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Japan
Frequently asked questions
Is Sodium Nitroprusside approved in Japan?
Yes. PMDA authorised it on 25 August 2021.
Who is the marketing authorisation holder for Sodium Nitroprusside in Japan?
MARUISHI PHARMACEUTICAL Co., Ltd holds the Japanese marketing authorisation.